Drug Insights

Is Twyneo approved by the FDA?

16 July 2024
3 min read

Yes, Twyneo is FDA approved. The U.S. Food and Drug Administration (FDA) approved Twyneo for use in the treatment of acne vulgaris on July 26, 2021. This approval allows the medication to be prescribed and used in the United States for its intended purposes.

Uses and Benefits

Twyneo combines benzoyl peroxide and tretinoin in a topical cream form, with concentrations of 3% and 0.1%, respectively. It is used to treat acne vulgaris in both adults and children aged 9 years and older. The combination of these two ingredients helps to reduce acne by addressing multiple factors that contribute to the condition, such as bacterial growth, clogged pores, and inflammation.

Administration and Dosage

Twyneo should be applied as follows:

  • Adults and Children 9 Years and Older: Apply a thin layer to the affected area once a day.
  • Instructions for Use:
    • Clean and dry the skin before application.
    • Apply the cream to the affected area, avoiding the eyes, lips, mouth, and other sensitive areas.
    • Wash hands thoroughly after applying the medication.
    • Store the medication at room temperature, away from moisture and heat. Do not freeze.
    • Dispose of the medication 30 days after opening or 12 weeks after receiving it, whichever comes first.

Side Effects

While Twyneo is generally well-tolerated, it can cause side effects. Common side effects include:

  • Skin irritation (dryness, pain, scaling, redness, peeling, stinging, or burning)
  • Swelling
  • Itching

Severe side effects may include signs of an allergic reaction, such as hives, difficulty breathing, and swelling of the face, lips, tongue, or throat. If severe side effects occur, seek medical attention immediately.

Precautions

Before using Twyneo, it is important to consider the following precautions:

  • Allergies: Do not use Twyneo if you are allergic to benzoyl peroxide or tretinoin.
  • Skin Conditions: Inform your doctor if you have conditions such as eczema, cuts, or sunburn, as these may affect the use of Twyneo.
  • Pregnancy and Breastfeeding: Consult your doctor if you are pregnant, planning to become pregnant, or breastfeeding.
  • Sun Sensitivity: Twyneo can increase sensitivity to sunlight. Avoid excessive sun exposure and use sunscreen (SPF 30 or higher) and protective clothing when outdoors.

Conclusion

Twyneo is an FDA-approved topical treatment for acne vulgaris, combining benzoyl peroxide and tretinoin for effective acne management. It is essential to follow the prescribed usage instructions and take necessary precautions to avoid side effects and ensure the best results. Always consult with a healthcare provider before starting any new medication.

How to obtain the latest development progress of all drugs?

In the Synapse database, you can stay updated on the latest research and development advances of all drugs. This service is accessible anytime and anywhere, with updates available daily or weekly. Use the "Set Alert" function to stay informed. Click on the image below to embark on a brand new journey of drug discovery!

图形用户界面, 文本, 应用程序, 电子邮件

描述已自动生成

图形用户界面, 文本, 应用程序, 电子邮件

描述已自动生成

图形用户界面, 文本, 应用程序, 聊天或短信

描述已自动生成

Context Therapeutics Acquires Phase 1-ready T Cell Engager CT-95
Latest Hotspot
3 min read
Context Therapeutics Acquires Phase 1-ready T Cell Engager CT-95
16 July 2024
Context Therapeutics Inc. has publicized the acquisition of CT-95, previously the property of Link Immunotherapeutics, Inc.
Read →
Is Belumosudil approved by the FDA?
Drug Insights
3 min read
Is Belumosudil approved by the FDA?
16 July 2024
The U.S. Food and Drug Administration (FDA) approved belumosudil on July 16, 2021.
Read →
Skyhawk Therapeutics Announces Successful Phase 1 Results for SKY-0515 in Huntington's Disease
Latest Hotspot
3 min read
Skyhawk Therapeutics Announces Successful Phase 1 Results for SKY-0515 in Huntington's Disease
16 July 2024
Skyhawk Therapeutics Reports Positive Topline Results from Phase 1 Trial of SKY-0515 for Huntington’s Disease, Achieving 72% Reduction in Huntingtin mRNA.
Read →
Is Finerenone approved by the FDA?
Drug Insights
2 min read
Is Finerenone approved by the FDA?
16 July 2024
The U.S. Food and Drug Administration (FDA) approved finerenone on July 9, 2021.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.